Toxic shock syndrome surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Toxic shock syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{CMG}} ==Overvi...")
 
m (Bot: Removing from Primary care)
 
(18 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Toxic shock syndrome}}
{{Toxic shock syndrome}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{CMG}}
{{CMG}},{{AE}}{{MIR}}
 
==Overview:==
[[Surgery]] is not the first-line treatment option for patients with [[toxic shock syndrome]](TSS). Surgical [[debridement]] is usually reserved for patients with either [[necrotizing fasciitis]](NF), and patients with deep-seeded [[pyogenic]] infection. [[Urgent care|Urgent]] surgical [[debridement]] was recommended for all patients who develop [[Necrotizing fasciitis|NF]] earlier, but is under questioning nowadays.
 
==Surgery==
Prompt, aggressive, immediate exploration and [[debridement]] of patients thought to have deep tissue localized [[infection]] was believed to be a [[surgical emergency]] <ref name="pmid9560122">{{cite journal |vauthors=Schurr M, Engelhardt S, Helgerson R |title=Limb salvage for streptococcal gangrene of the extremity |journal=Am. J. Surg. |volume=175 |issue=3 |pages=213–7 |year=1998 |pmid=9560122 |doi= |url=}}</ref>. Surgical [[exploration]] of the susceptible infected tissue may help with the early and definitive diagnosis of NF. In NF related [[Toxic shock syndrome|TSS]] patients, infection usually is more extensive than is apparent from external examination. Although the necessity of surgical [[debridement]], the recommendation of immediate radical excision of [[necrotic tissue]] in patients with [[Streptococcus|streptococcal]] TSS NF is not supported by clinical studies and should be reconsidered as an emergency treatment in TSS management<ref name="pmid7553574">{{cite journal |vauthors=Kotb M |title=Bacterial pyrogenic exotoxins as superantigens |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=411–26 |year=1995 |pmid=7553574 |pmc=174633 |doi= |url=}}</ref>.
 
==Indications==
Surgical [[debridement]] of body tissues should be considered in these patients:
* [[Localized disease|Localized]] source of [[infection]] is diagnosed
* [[Streptococcus|Streptococcal]] [[Necrotizing fasciitis|NF]]-related [[Toxic shock syndrome|TSS]] patients<ref name="urlChapter 125. Infections of the Skin, Muscles, and Soft Tissues | Harrisons Principles of Internal Medicine, 18e | AccessMedicine | McGraw-Hill Medical">{{cite web |url=http://accessmedicine.mhmedical.com/content.aspx?bookid=331&sectionid=40726869 |title=Chapter 125. Infections of the Skin, Muscles, and Soft Tissues &#124; Harrison's Principles of Internal Medicine, 18e &#124; AccessMedicine &#124; McGraw-Hill Medical |format= |work= |accessdate=}}</ref>


==Overview==
One of the symptoms of streptococcal toxic shock syndrome is extreme infection of the skin and deeper parts is called [[fasciitis necroticans|necrotizing fasciitis]]. This often requires prompt surgical treatment.
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 15: Line 23:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Syndromes]]
[[Category:Syndromes]]
[[Category:Needs content]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Needs content]]

Latest revision as of 00:27, 30 July 2020

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome surgery

CDC on Toxic shock syndrome surgery

Toxic shock syndrome surgery in the news

Blogs on Toxic shock syndrome surgery

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview:

Surgery is not the first-line treatment option for patients with toxic shock syndrome(TSS). Surgical debridement is usually reserved for patients with either necrotizing fasciitis(NF), and patients with deep-seeded pyogenic infection. Urgent surgical debridement was recommended for all patients who develop NF earlier, but is under questioning nowadays.

Surgery

Prompt, aggressive, immediate exploration and debridement of patients thought to have deep tissue localized infection was believed to be a surgical emergency [1]. Surgical exploration of the susceptible infected tissue may help with the early and definitive diagnosis of NF. In NF related TSS patients, infection usually is more extensive than is apparent from external examination. Although the necessity of surgical debridement, the recommendation of immediate radical excision of necrotic tissue in patients with streptococcal TSS NF is not supported by clinical studies and should be reconsidered as an emergency treatment in TSS management[2].

Indications

Surgical debridement of body tissues should be considered in these patients:

References

  1. Schurr M, Engelhardt S, Helgerson R (1998). "Limb salvage for streptococcal gangrene of the extremity". Am. J. Surg. 175 (3): 213–7. PMID 9560122.
  2. Kotb M (1995). "Bacterial pyrogenic exotoxins as superantigens". Clin. Microbiol. Rev. 8 (3): 411–26. PMC 174633. PMID 7553574.
  3. "Chapter 125. Infections of the Skin, Muscles, and Soft Tissues | Harrison's Principles of Internal Medicine, 18e | AccessMedicine | McGraw-Hill Medical".


Template:WikiDoc Sources